Research Review: Ketamine VS Morphine for Acute Pain Relief in the ER

Ketamine shows better, faster relief with fewer adverse events than morphine.

Effective pain management is crucial in emergency departments (EDs), where patients often present with severe acute pain from conditions like trauma, fractures, kidney stones, burns, and abdominal pain. While opioids like morphine are commonly used, they come with a risk of dose-dependent adverse effects like respiratory depression, nausea, vomiting, and constipation.

A recent meta-analysis published in The American Journal of Emergency Medicine has taken a closer look at using low-dose ketamine as an alternative to morphine for acute pain relief in the ED setting. The researchers analyzed data from 15 randomized controlled trials involving a total of 1,768 adult patients.s

The Findings:

  • Rapid pain relief: ketamine led to more complete pain resolution at 15 minutes post-administration

  • Early pain relief: at 30 minutes post-treatment, ketamine significantly reduced pain scores more than morphine

  • Long-term relief: morphine showed superior analgesic effects at 120 minutes

  • Adverse events: ketamine had a lower incidence of adverse events requiring intervention

The authors conclude that while morphine maintains more durable analgesic effects over time, ketamine provides better initial pain control with a lower risk of adverse events requiring medical intervention.

These findings suggest ketamine could be a viable option for acute pain management in EDs, potentially allowing faster initial relief with a better side effect profile compared to conventional opioid treatment with morphine.

Of course, more research is still needed on optimal dosing and weighing the benefits against any potential risks of ketamine administration. But this meta-analysis provides supportive evidence for considering ketamine as part of a multimodal approach to acute pain treatment in the emergency setting.

Previous
Previous

Research Review: 1 Single Low Dose of Esketamine after Childbirth Shows Promise for PPD

Next
Next

IV Ketamine Shows Potential Promise for Refractory Headache in Children